Hyperion
A new device has been created for cancer screening and early diagnosis.
A new device has been created for cancer screening and early diagnosis.
Hyperion is a Turkish-based startup that has developed a novel device for cancer screening and early diagnosis. Founded in 2022, the company operates within the Digital Health, Health Care, Health and Wellness, and Healthtech industries, aiming to revolutionize the way cancer is screened and diagnosed.
Their slogan, "A new device has been created for cancer screening and early diagnosis," emphasizes their commitment to advancing healthcare through technological innovation.
Although specific details about their last investment and investors are currently unavailable, Hyperion's overarching mission is articulated through a grandiose description that emphasizes their dedication to exploring cultural expressions and traditions as a means of shaping the world through creativity and innovation.
With its headquarters situated in Turkey, Hyperion exemplifies the potential for groundbreaking advancements in healthcare that are emerging from diverse global locations.
There is no investment information
No recent news or press coverage available for Hyperion.
We care about your data, and we'd love to use cookies make your experience better.